Physician profile
Viktor E Krebs
NPI 1538136965
$7,533,936.18
in general payments reported to CMS, 2019-2025
8 companies · $1.5M in 2025
The $1.5M reported for 2025 was more than what 99% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $901K · 2020: $761K · 2021: $822K · 2022: $899K · 2023: $1.2M · 2024: $1.4M · 2025: $1.5M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $4.0M · Travel and Lodging: $57K · Consulting Fee: $39K · Food and Beverage: $9,973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $4,044,314.18 |
| Travel and Lodging | $57,344.47 |
| Consulting Fee | $39,000.00 |
| Food and Beverage | $9,973.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,532,288.38 | 2019-2025 | Accolade, Triathlon, Trident |
| Zimmer Biomet Holdings, INC. | $671.53 | 2023-2025 | Persona, Rosa, Arcos |
| Medtronic, INC. | $307.27 | 2022-2025 | Aquamantys(Tm) |
| Onkos Surgical, INC. | $282.14 | 2022-2025 | Eleos Limb Salvage System |
| Encore Medical, Lp | $146.52 | 2022 | |
| Medtronic USA, INC. | $136.39 | 2019 | |
| Anika Therapeutics, INC. | $103.95 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Viktor Krebs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.